Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Return on Sales: 2021-2025

Historic Return on Sales for Molecular Partners Ag (MOLN) over the last 4 years, with Sep 2025 value amounting to -8.72%.

  • Molecular Partners Ag's Return on Sales rose 25.00% to -8.72% in Q3 2025 from the same period last year, while for Sep 2025 it was -8.72%, marking a year-over-year increase of 25.00%. This contributed to the annual value of -10.87% for FY2024, which is 207.00% down from last year.
  • Molecular Partners Ag's Return on Sales amounted to -8.72% in Q3 2025, which was down 0.00% from -8.72% recorded in Q2 2025.
  • Molecular Partners Ag's 5-year Return on Sales high stood at 0.62% for Q4 2022, and its period low was -10.61% during Q1 2025.
  • For the 3-year period, Molecular Partners Ag's Return on Sales averaged around -6.89%, with its median value being -8.97% (2024).
  • The largest annual percentage gain for Molecular Partners Ag's Return on Sales in the last 5 years was 392bps (2023), contrasted with its biggest fall of 1,106bps (2023).
  • Quarterly analysis of 5 years shows Molecular Partners Ag's Return on Sales stood at -2.43% in 2021, then surged by 245bps to 0.62% in 2022, then crashed by 1,106bps to -10.44% in 2023, then dropped by 17bps to -10.61% in 2024, then grew by 25bps to -8.72% in 2025.
  • Its Return on Sales was -8.72% in Q3 2025, compared to -8.72% in Q2 2025 and -10.61% in Q1 2025.